{"name":"MVM Life Science Partners","permalink":"mvm-life-science-partners","crunchbase_url":"http://www.crunchbase.com/financial-organization/mvm-life-science-partners","homepage_url":"http://www.mvmlifescience.com","blog_url":"","blog_feed_url":"","twitter_username":"","phone_number":"44-(0)20-7557-7500","description":"Life Sciences Investment","email_address":"","number_of_employees":null,"founded_year":1997,"founded_month":null,"founded_day":null,"tag_list":null,"alias_list":"","created_at":"Tue Nov 10 23:39:58 UTC 2009","updated_at":"Thu Dec 03 20:09:19 UTC 2009","overview":"<p>MVM was founded in 1997 and manages three funds totalling more than US$500 million. MVM has invested in biopharmaceuticals, diagnostics, drug delivery, gene therapy, healthcare services, medical devices, OTC medicines, research tools and vaccines. </p>","image":{"available_sizes":[[[150,88],"assets/images/resized/0006/8440/68440v1-max-150x150.jpg"],[[166,98],"assets/images/resized/0006/8440/68440v1-max-250x250.jpg"],[[166,98],"assets/images/resized/0006/8440/68440v1-max-450x450.jpg"]],"attribution":null},"offices":[{"description":"","address1":"6 Henrietta Street","address2":"","zip_code":"WC2E 8PU","city":"London","state_code":null,"country_code":"GBR","latitude":null,"longitude":null}],"relationships":[],"investments":[{"funding_round":{"round_code":"f","source_url":"http://www.xconomy.com/boston/2009/11/10/biovex-nails-down-another-30m-to-finish-pivotal-study-of-cancer-killing-virus/","source_description":"Xconomy Boston","raised_amount":30000000,"raised_currency_code":"USD","funded_year":2009,"funded_month":11,"funded_day":10,"company":{"name":"BioVex","permalink":"biovex","image":{"available_sizes":[[[150,40],"assets/images/resized/0004/9487/49487v2-max-150x150.jpg"],[[250,68],"assets/images/resized/0004/9487/49487v2-max-250x250.jpg"],[[294,80],"assets/images/resized/0004/9487/49487v2-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"http://onbiovc.com/tarsa-therapeutics-inc-series-a-24m/","source_description":"Tarsa Therapeutics, Inc.: Series A $24M","raised_amount":24000000,"raised_currency_code":"USD","funded_year":2010,"funded_month":1,"funded_day":17,"company":{"name":"Tarsa Therapeutics","permalink":"tarsa-therapeutics","image":{"available_sizes":[[[150,80],"assets/images/resized/0007/4051/74051v1-max-150x150.jpg"],[[250,134],"assets/images/resized/0007/4051/74051v1-max-250x250.jpg"],[[345,186],"assets/images/resized/0007/4051/74051v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://onbiovc.com/cheetah-medical-inc-series-b-20m/","source_description":"Cheetah Medical, Inc.: Series B $20M ","raised_amount":20000000,"raised_currency_code":"USD","funded_year":2010,"funded_month":4,"funded_day":6,"company":{"name":"Cheetah Medical","permalink":"cheetah-medical","image":{"available_sizes":[[[150,68],"assets/images/resized/0008/2950/82950v1-max-150x150.png"],[[163,74],"assets/images/resized/0008/2950/82950v1-max-250x250.png"],[[163,74],"assets/images/resized/0008/2950/82950v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"http://www.thefreelibrary.com/Cara+Therapeutics+Secures+$19+Million+in+Series+C+Financing.-a0155078851","source_description":"Cara Therapeutics Secures $19 Million in Series C Financing.","raised_amount":19000000,"raised_currency_code":"USD","funded_year":2006,"funded_month":11,"funded_day":28,"company":{"name":"Cara Therapeutics","permalink":"cara-therapeutics","image":{"available_sizes":[[[150,57],"assets/images/resized/0008/4286/84286v1-max-150x150.jpg"],[[197,76],"assets/images/resized/0008/4286/84286v1-max-250x250.jpg"],[[197,76],"assets/images/resized/0008/4286/84286v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"d","source_url":"http://www.fiercebiotech.com/story/cara-rounds-15m-post-op-pain-drug/2010-07-21?utm_medium=rss&utm_source=rss","source_description":"Cara rounds up $15M for post-op pain drug  Read more: Cara rounds up $15M for post-op pain drug","raised_amount":15000000,"raised_currency_code":"USD","funded_year":2010,"funded_month":7,"funded_day":21,"company":{"name":"Cara Therapeutics","permalink":"cara-therapeutics","image":{"available_sizes":[[[150,57],"assets/images/resized/0008/4286/84286v1-max-150x150.jpg"],[[197,76],"assets/images/resized/0008/4286/84286v1-max-250x250.jpg"],[[197,76],"assets/images/resized/0008/4286/84286v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://www.finsmes.com/2010/11/vascular-pathways-closes-14m-series-b.html","source_description":"Vascular Pathways Closes $14M Series B Financing","raised_amount":14000000,"raised_currency_code":"USD","funded_year":2010,"funded_month":11,"funded_day":1,"company":{"name":"Vascular Pathways","permalink":"vascular-pathways","image":null}}},{"funding_round":{"round_code":"b","source_url":"http://www.vantiatherapeutics.com/news/news/vantia_pr_060711.pdf","source_description":"Vantia Therapeutics Raises Â£4 Million to Fund Clinical Development of its Lead Compounds","raised_amount":6500000,"raised_currency_code":"USD","funded_year":2011,"funded_month":7,"funded_day":6,"company":{"name":"Vantia Therapeutics","permalink":"vantia-therapeutics","image":{"available_sizes":[[[150,59],"assets/images/resized/0014/2809/142809v1-max-150x150.png"],[[247,98],"assets/images/resized/0014/2809/142809v1-max-250x250.png"],[[247,98],"assets/images/resized/0014/2809/142809v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://www.finsmes.com/2011/07/accuvein-secures-22-5m-series-financing.html?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+finsmes%2FcNHu+%28FinSMEs%29","source_description":"AccuVein Secures $22.5M in Series B Financing","raised_amount":22500000,"raised_currency_code":"USD","funded_year":2011,"funded_month":7,"funded_day":28,"company":{"name":"AccuVein","permalink":"accuvein","image":{"available_sizes":[[[150,25],"assets/images/resized/0014/6808/146808v1-max-150x150.png"],[[223,38],"assets/images/resized/0014/6808/146808v1-max-250x250.png"],[[223,38],"assets/images/resized/0014/6808/146808v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"unattributed","source_url":"http://www.masshightech.com/stories/2011/08/01/daily7-Beacon-Endoscopic-draws-5M-funding.html","source_description":"Beacon Endoscopic draws $8M in two fundings","raised_amount":8000000,"raised_currency_code":"USD","funded_year":2011,"funded_month":8,"funded_day":1,"company":{"name":"Beacon Endoscopic","permalink":"beacon-endoscopic","image":{"available_sizes":[[[150,83],"assets/images/resized/0014/7375/147375v1-max-150x150.jpg"],[[150,83],"assets/images/resized/0014/7375/147375v1-max-250x250.jpg"],[[150,83],"assets/images/resized/0014/7375/147375v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"http://onbiovc.com/horizon-discovery-ltd-series-c-186m/","source_description":"Horizon Discovery, Ltd.: Series C $18.6M","raised_amount":18600000,"raised_currency_code":"USD","funded_year":2012,"funded_month":1,"funded_day":16,"company":{"name":"Horizon Discovery","permalink":"horizon-discovery","image":{"available_sizes":[[[150,56],"assets/images/resized/0004/7571/47571v3-max-150x150.png"],[[250,94],"assets/images/resized/0004/7571/47571v3-max-250x250.png"],[[450,169],"assets/images/resized/0004/7571/47571v3-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://www.prnewswire.com/news-releases/tarsa-therapeutics-completes-28-million-series-b-financing-to-advance-ostora-oral-calcitonin-142908965.html","source_description":"Tarsa Therapeutics Completes $28 Million Series B Financing to Advance OSTORA™ Oral Calcitonin","raised_amount":28000000,"raised_currency_code":"USD","funded_year":2012,"funded_month":3,"funded_day":16,"company":{"name":"Tarsa Therapeutics","permalink":"tarsa-therapeutics","image":{"available_sizes":[[[150,80],"assets/images/resized/0007/4051/74051v1-max-150x150.jpg"],[[250,134],"assets/images/resized/0007/4051/74051v1-max-250x250.jpg"],[[345,186],"assets/images/resized/0007/4051/74051v1-max-450x450.jpg"]],"attribution":null}}}}],"milestones":[],"providerships":[],"funds":[],"video_embeds":[],"external_links":[]}